Patents by Inventor Oliver WERZ

Oliver WERZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREPARATION COMPRISING OMEGA-3 FATTY ACID SALTS AND EXTRACTS OF GUM RESINS FROM BOSWELLIA SPECIES
    Publication number: 20220265749
    Abstract: Preparations may include at least one extract of gum resins from Boswellia species and at least one omega-3 fatty acid salt selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Surprisingly, such combinations of extracts of gum resins from Boswellia species and polyunsaturated fatty acid salt can cause a marked and unexpected increase in the biosynthesis of specialized pro-resolving mediators (SPM) in a synergistic manner, proposing benefit for resolution of inflammatory conditions.
    Type: Application
    Filed: July 30, 2020
    Publication date: August 25, 2022
    Applicant: Evonik Operations GmbH
    Inventors: Mario GOMEZ, Bodo SPECKMANN, Michael SCHWARM, Oliver WERZ
  • Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases
    Patent number: 10494357
    Abstract: The present invention relates to compounds of formula (III) or to compounds of formula (IV) wherein R1, R2, R3 and R4 are as defined in the claims, and their use in therapeutic treatments of 5-lipoxygenase related diseases such as chronic airway inflammatory or dermatological disorders.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: December 3, 2019
    Assignees: UNIVERSITÉ D'ANGERS, UNIVERSITÄT INNSBRUCK, FRIEDRICH-SCHILLER-UNIVERSITÄT JENA
    Inventors: Pascal Richomme, Jean-Jacques Helesbeux, David Guilet, Denis Seraphin, Hermann Stuppner, Birgit Waltenberger, Daniela Schuster, Veronika Sophie Temml, Andreas Koeberle, Oliver Werz
  • TOCOTRIENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN 5-LIPOXYGENASE RELATED DISEASES
    Publication number: 20190144413
    Abstract: The present invention relates to compounds of formula (III) or to compounds of formula (IV) wherein R1, R2, R3 and R4 are as defined in the claims, and their use in therapeutic treatments of 5-lipoxygenase related diseases such as chronic airway inflammatory or dermatological disorders.
    Type: Application
    Filed: August 26, 2016
    Publication date: May 16, 2019
    Inventors: Pascal RICHOMME, Jean-Jacques HELESBEUX, David GUILET, Denis SERAPHIN, Hermann STUPPNER, Birgit WALTENBERGER, Daniela SCHUSTER, Veronika Sophie TEMML, Andreas KOEBERLE, Oliver WERZ